Play therapy may boost social skills in infants with tuberous sclerosis — a trial puts it to the test

NCT ID NCT02687633

Completed Symptom relief Sponsor: University of California, Los Angeles Source: ClinicalTrials.gov ↗

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This trial tests whether JASPER, a play-based behavioral intervention, can improve social communication and play skills in infants (12–36 months) with tuberous sclerosis complex (TSC). Caregivers learn strategies during daily and weekly sessions to support their child's development. The study measures changes in joint engagement and attention over six months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: JASPER (Joint Attention, Symbolic Play, Engagement, and Regulation) — a play-based behavioral intervention
What this could lead to: If effective, this approach could offer a non-drug way to boost social communication and play skills in young children with tuberous sclerosis complex.
What could go wrong: This is a very small, early-stage trial with only 8 participants, so results may not apply broadly. The intensive daily sessions may be challenging for families.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TUBEROUS SCLEROSIS COMPLEX are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

tuberous sclerosis tuberous sclerosis 1

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TUBEROUS SCLEROSIS COMPLEX

Contacts and locations

Show contact details

Locations

UCLA Semel Insitute

Los Angeles, California, 90095, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.